Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems
NCT: NCT07491367 · RECRUITING
Brief Summary
The investigators would like to study the differences in the quality of Platelet Rich Plasma (PRP) between two different machines in those with knee osteoarthritis. Knee osteoarthritis means your cartilage has been worn down, and it affects your knee joint. Both machines, the APEX Biologix XCELL PRP System and the Emcyte PurePRP Supraphysiologic Concentrating System, are FDA approved, commercially available, and makes PRP. The investigators will check if the platelets in the PRP have different amounts or work differently. The investigators will also assess participants symptoms after the injection and compare the two different preparation systems.
Frequently Asked Questions
What is Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems?
Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems is a clinical trial registered under NCT07491367. Current status: RECRUITING.
What is the status of NCT07491367?
The current status of NCT07491367 (Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems) is: RECRUITING.
When did Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems start?
Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems started on 2026-09-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.